about
Safety and efficacy of different lanreotide doses in the treatment of polycystic liver disease: pooled analysis of individual patient data.Reasons for dose reduction of mycophenolate mofetil during the first year after renal transplantation and its impact on graft outcome.p-Cresyl sulfate and indoxyl sulfate in hemodialysis patients.Cardiovascular disease relates to intestinal uptake of p-cresol in patients with chronic kidney disease.p-Cresol and cardiovascular risk in mild-to-moderate kidney diseaseDetoxifying capacity and kinetics of the molecular adsorbent recycling system. Contribution of the different inbuilt filters.Measuring total blood calcium displays a low sensitivity for the diagnosis of hypercalcemia in incident renal transplant recipients.The histology of kidney transplant failure: a long-term follow-up study.Proteinuria as a Noninvasive Marker for Renal Allograft Histology and Failure: An Observational Cohort Study.Prometheus versus molecular adsorbents recirculating system: comparison of efficiency in two different liver detoxification devices.Purple Urine Bag Syndrome in Two Elderly Men with Urinary Tract InfectionRecovery of hyperphosphatoninism and renal phosphorus wasting one year after successful renal transplantationCalcium metabolism in the early posttransplantation period.A review of albumin binding in CKD.Cladophialophora bantiana osteomyelitis in a renal transplant patient.Renal clearance and intestinal generation of p-cresyl sulfate and indoxyl sulfate in CKD.Diabetic muscle infarction: a rare cause of acute limb pain in dialysis patients.Serum concentrations of p-cresyl sulfate and indoxyl sulfate, but not inflammatory markers, increase in incident peritoneal dialysis patients in parallel with loss of residual renal function.Urea and uremic solutes: how does peritoneal dialysis work?Systematic review: the pathophysiology and management of polycystic liver disease.Association of HO-1 (GT)n Promoter Polymorphism and Cardiovascular Disease: A Reanalysis of the Literature.Decreased Circulating Sclerostin Levels in Renal Transplant Recipients With Persistent Hyperparathyroidism.Phosphorus metabolism in peritoneal dialysis- and haemodialysis-treated patients.Sclerostin Serum Levels and Vascular Calcification Progression in Prevalent Renal Transplant Recipients.The effect of anastomosis time on outcome in recipients of kidneys donated after brain death: a cohort study.Invasive aspergillosis after kidney transplant: case-control study.Microscopic nephrocalcinosis in chronic kidney disease patients.Clinicians' attitude towards family planning and timing of diagnosis in autosomal dominant polycystic kidney disease.Immunogenicity of a standard trivalent influenza vaccine in patients on long-term hemodialysis: an open-label trial.Maintenance immunosuppressive agents as risk factors for BK virus nephropathy: the need for true drug exposure measurements.Fluctuations of haemoglobinaemia in chronic haemodialysis patients.Chronic histological damage in early indication biopsies is an independent risk factor for late renal allograft failure.Localization, etiology and impact of calcium phosphate deposits in renal allografts.A single-centre study of adjuvant cidofovir therapy for BK virus interstitial nephritis (BKVIN) in renal allograft recipients.Combined kidney and intestinal transplantation in patients with enteric hyperoxaluria secondary to short bowel syndrome.Removal of the protein-bound solute p-cresol by convective transport: a randomized crossover study.AA amyloidosis due to chronic oxalate arthritis and vasculitis in a patient with secondary oxalosis after jejunoileal bypass surgery.The influence of renal transplantation on retained microbial-human co-metabolites.Detoxifying capacity and kinetics of prometheus--a new extracorporeal system for the treatment of liver failure.Gas chromatographic-mass spectrometric analysis for measurement of p-cresol and its conjugated metabolites in uremic and normal serum.
P50
Q30651564-3B789329-BF21-4A1E-BC7E-3FAF9B184945Q33408239-498223DB-A65B-44A6-9543-CDBCE0441B2AQ33560454-EC46AA90-7E9F-409F-B7EC-731509E11F5CQ33780255-52FF3830-CE88-4D70-98F3-39CC92285F42Q33944858-E3BD510C-354D-44E1-A1FC-EBE0F3F81954Q34202648-E27D32DE-11E4-4699-AD6C-A044E69C34CBQ34405366-A962867E-226A-47B7-BA7C-315262625F93Q34439824-3A9CB7A7-D585-45F2-90A9-CB0902A8FC0BQ34483895-7BC9E048-43F7-412C-98FA-CE08B083D0F4Q34518397-304330E8-54B4-4F4E-BAEE-653DE7D8F5ABQ36006476-7CBF4211-D2AF-4D07-A837-1136F651CF2EQ36947345-4EAC5C48-1202-4DBC-8D62-A7575FF6FFFFQ37123164-6D92084E-F5FC-4109-83D8-D41E6B82372AQ37147391-744CF704-6B2E-4D0C-A020-C241EFCC55FFQ37199209-25C17656-DA62-4370-9E8E-8300352EBF24Q37246931-982DF4F9-DEE6-4EE8-B886-D3B83EBC0E2EQ37556253-96B3B5F8-996A-4BA6-9B53-C11AAFDCC16BQ37582625-0D08C1B0-7C63-47BD-A416-461640D0E854Q37857966-7EA66623-7110-437C-9C2B-80F482FC28CBQ37905881-1F18551A-8C9D-4671-8794-BD98C9FDEE0BQ38611673-57DF3A7B-4D4B-4151-AAB8-5B688F9E7CCEQ39630789-A4E99169-1EFE-48E2-8211-9AF01A1579DBQ39973995-092038DD-F46C-4046-82AC-96A2B95809FDQ40387863-D3960E94-9822-46BF-AD8F-3946D19D5F09Q40410816-CAA6A466-DF72-40CF-B009-9DB5A6AD9D4CQ41483647-C3EDA040-241D-4D10-851D-6D8F77265416Q41586193-71C56007-5277-4222-A678-3441877C75E0Q42367550-CDD4DC94-1372-4782-8A77-C331BB9D103CQ42616627-BA86CB5C-4A85-4FAD-BA8C-0C710D361356Q43016480-CD6921FC-0955-41E0-8254-1F0076ACE130Q43849765-4B5EC57C-9308-48E4-B9C2-E76D68D65E9DQ44276263-D092B7B3-D062-42DC-984E-CB28DA2D938DQ44432001-64CC2C91-E4A7-442B-B91A-E39688157503Q44598598-44E62F30-0FF4-4C8C-ACCC-4CC76428909DQ44776130-45689D10-E6D2-4076-B4F9-B13B9EB0C943Q44985968-84FD6083-1FFB-4793-9BED-A54ADC529BC6Q46480227-5ECB4C3B-C6BD-47C3-A2CB-FC8C7143C13AQ46582267-0FE3EFD4-54BB-4290-8075-96F509B820A2Q46601873-CBC47401-7C86-40F8-8242-A2BED221E22DQ46616212-56633CDF-BE26-4AC2-94A0-7BAAE8A8B02A
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Bert Bammens
@ast
Bert Bammens
@en
Bert Bammens
@es
Bert Bammens
@nl
Bert Bammens
@sl
type
label
Bert Bammens
@ast
Bert Bammens
@en
Bert Bammens
@es
Bert Bammens
@nl
Bert Bammens
@sl
prefLabel
Bert Bammens
@ast
Bert Bammens
@en
Bert Bammens
@es
Bert Bammens
@nl
Bert Bammens
@sl
P106
P21
P31
P496
0000-0002-2477-2633